Research and Development

For many years since the start of our firm in 1981, we have been providing legal services to domestic and overseas pharmaceutical companies, medical device manufactures, bio-venture companies, research institutes, contract research organizations (CROs) and various other clients. Our services include advising such clients on license agreements (patents, trademarks, etc.), research and development agreements, clinical research agreements and material transfer agreements.
Recently, the lawyers who have expert knowledge and experience provide legal advice on cutting-edge areas such as iPS cells, antibody drugs, regenerative medicine, gene therapy, biotechnology and telemedicine from the view of intellectual property law, personal information protection law and other laws specific to such areas. In addition, we have a contracted advisor who is a former government official of the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA), which enables us to provide more practical and quality legal advice.

Contact us

PublicationsArchives

2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.07.04
China's Life Sciences and Healthcare-No.2 -The Good Vigilance Practice rule in China
2022.03.14
A Legal Review of China's Life Sciences and 2 Healthcare- No.1 -General Introduction and MAH System
2022.02.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2021.11.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 4) - Developments in Amendment of Regulations Concerning Wholesaling/Retailing of Pharmaceutical Products, Etc. (Measures on Supervision and Control of the Drug Business and Usage Quality (Draft
2021.10.28
Legal Affairs for Chinese Life Sciences and Healthcare (Part 3) -Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (2)
2021.09.30
Legal Affairs for Chinese Life Sciences and Healthcare (Part 2) -Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (1)
2021.08.30
Legal Affairs for Chinese Life Sciences and Healthcare

MORE

SeminarsArchives

MORE

ページTOPへ